can i breastfeed on semaglutide and Breastfeeding: Safety Facts Semaglutide and Breastfeeding Safety |

J.VilstrupH.GeorgeJ.et al (2019)

Common infections such as syphilis, chancroid, and lymphogranuloma venereum frequently lead to groin lymph node swelling

Functionally, MAPKAPK2 overexpression mitigated oxidative damage, restored antioxidant capacity, and attenuated markers of DNA damage and cellular dysfunction, suggesting a cytoprotective role under oxidative conditions

Wegovy Tablets: Initial dose (days 1 through 30): 1.5 mg orally once a day Dose escalation: Days 31 through 60: 4 mg orally once a day Days 61 through 90: 9 mg orally once a day SUBCUTANEOUS: Ozempic Injection: Initial dose: 0.25 mg subcutaneously once a week for 4 weeks, then 0.5 mg subcutaneously once a week Maintenance dose for glycemic control: 0.5 to 2 mg subcutaneously once a week, based on glycemic control If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dose: Increase to 1 mg subcutaneously once a week

doi:10.1001/jamanetworkopen.2024.27258 38

Funding Support for this work was provided by US National Institutes of Health grants R56DK123738 and R01DK123738 to E.E.S